Clinical trial Recruiting at 1 site Observational Ages 18 and up Women only

Understanding angiogenic function in normal term pregnancies

Official title: Angiogenic Function at Normal Term on Placenta

Run by Centre Hospitalier Intercommunal Creteil · NCT03981653 · Data updated 2026-11-12

This study looks at how certain cells in healthy pregnancies help with blood vessel growth in the placenta to see if it can lead to better treatments for pregnancy problems like pre-eclampsia.

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment750 (estimated)
SponsorCentre Hospitalier Intercommunal Creteil
Academic / other
Locations1 site (Créteil)
StatusRecruiting
StartedMarch 20, 2019
Main results expectedMarch 2029
Study endsMarch 2029
Registry record updatedDecember 21, 2022
Trial IDNCT03981653 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include women with strictly normal pregnancies or those with specific complications like gestational diabetes or pregnancy cholestasis, who are scheduled for cesarean delivery after 37 weeks.

Probably not a fit

Patients with multiple pregnancies, known major fetal malformations, or those experiencing pre-eclampsia or intrauterine growth restriction will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the angiogenic function of trophoblasts in placentas from healthy pregnancies at term. It aims to analyze the expression of pro- and antiangiogenic factors, such as placenta growth factor (PlGF) and soluble FMS-like tyrosine kinase-1 (sFlt-1), in human differentiated trophoblastic cells. The study will also explore the effects of various chemical compounds on placental functions and trophoblastic differentiation, potentially identifying therapeutic targets for pregnancy-related pathologies like pre-eclampsia and intrauterine growth restriction. By measuring gene and protein expression variations, the research seeks to enhance understanding of placental pathophysiology.

Why it matters

Potential benefit: If successful, this study could lead to new therapeutic strategies for managing pregnancy complications related to placental dysfunction.

How similar studies have gone: While this study explores a specific aspect of placental function, similar studies have shown promise in understanding angiogenic factors in pregnancy-related conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnancies with scheduled cesarean delivery \>37 weeks of amenorrhea:
* strictly normal pregnancies
* complicated pregnancies of gestational diabetes, insulin-treated or not
* complicated pregnancies due to pregnancy cholestasis
* spontaneous or in vitro fecondation (IVF) / Intracytoplasmic sperm injection (ICSI) pregnancies with or without oocyte donation

Exclusion Criteria:

* Patient's opposition
* Age \< 18 years old
* Women under the protection of justice
* Multiple pregnancy
* Known major fetal malformation
* Pre-eclampsia and intrauterine growth retardation
* Placental insertionnomaly
* Type 1 diabetes
* HIV-positive patient with HIV/hepatisis C virus (HCV) regardless of viral load
* Patient in labour at the time of Caesarean section
* Patient whose medical history results in medication being taken in pregnancy courses that may interfere with the biology of the trophoblast (immunomodulators in case of autoimmune diseases, anti-rejection drugs in case of transplant patients)

Where it's running

  • Centre Hospitalier Intercommunal de Créteil
    Créteil, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.